Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
Identifieur interne : 008D60 ( Main/Merge ); précédent : 008D59; suivant : 008D61Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
Auteurs : Gokhan S. Hotamisligil [États-Unis] ; A. Sule Girmen [États-Unis] ; J. Stephen Fink [États-Unis] ; Elizabeth Tivol [États-Unis] ; Christo Shalish [États-Unis] ; James Trofatter [États-Unis] ; John Baenziger [États-Unis] ; Shirley Diamond [États-Unis] ; Charles Markham [États-Unis] ; Jack Sullivan [États-Unis] ; John Growdon [États-Unis] ; Xandra O. Breakefield [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1994.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Alleles, Child, Child, Preschool, Gene Frequency (genetics), Genetic Variation, Haplotypes (genetics), Humans, Infant, Isoenzymes (blood), Isoenzymes (genetics), Male, Middle Aged, Monoamine Oxidase (blood), Monoamine Oxidase (genetics), Monoamine oxidase, Parkinson Disease (enzymology), Parkinson Disease (genetics), Parkinson's disease, Polymorphism, Restriction Fragment Length.
- MESH :
- chemical , blood : Isoenzymes, Monoamine Oxidase.
- enzymology : Parkinson Disease.
- genetics : Gene Frequency, Haplotypes, Isoenzymes, Monoamine Oxidase, Parkinson Disease.
- Adolescent, Adult, Aged, Aged, 80 and over, Alleles, Child, Child, Preschool, Genetic Variation, Humans, Infant, Male, Middle Aged, Polymorphism, Restriction Fragment Length.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of dopaminergic neurons in the brainstem. Recent studies suggest that several genes may have a role in determining individual susceptibility to this disease, and the degradative enzyme monoamine oxidase (MAO) has been implicated in the disease process. Wide differences in activity levels for both forms of this enzyme (MAO‐A and MAO‐B) exist in the human population, and levels of both are genetically determined. Here we have compared the frequency of haplotypes at the MAOA and MAOB loci on the X chromosome in 91 male patients with PD and 129 male controls. Alleles were marked using two restriction fragment length polymorphisms (RFLPs), a (GT)n repeat in the MAOA locus, and a (GT)n repeat in the MAOB locus. One particular haplotype marked by the RFLP's at MAOA was three times more frequent in patients with PD as compared with controls, and the overall distribution of these alleles was significantly different (p =0.03) between these two groups. Another MAOA haplotype was about threefold more common in controls than in patients with PD (p = 0.005). No associations were observed between individual MAOB alleles and the disease state, but the frequency distribution for all alleles was significantly different in the two populations (p = 0.046). These findings support the idea that the MAO genes may be among the herediatary factors that influence susceptibility of individuals to PD.
Url:
DOI: 10.1002/mds.870090304
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000D97
- to stream Istex, to step Curation: 000D97
- to stream Istex, to step Checkpoint: 003F04
- to stream PubMed, to step Corpus: 004B16
- to stream PubMed, to step Curation: 004B16
- to stream PubMed, to step Checkpoint: 004B18
- to stream Ncbi, to step Merge: 004810
- to stream Ncbi, to step Curation: 004810
- to stream Ncbi, to step Checkpoint: 004810
Links to Exploration step
ISTEX:64432B267293EF1A4DE75E647985C6411C139AD7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease</title>
<author><name sortKey="Hotamisligil, Gokhan S" sort="Hotamisligil, Gokhan S" uniqKey="Hotamisligil G" first="Gokhan S." last="Hotamisligil">Gokhan S. Hotamisligil</name>
</author>
<author><name sortKey="Girmen, A Sule" sort="Girmen, A Sule" uniqKey="Girmen A" first="A. Sule" last="Girmen">A. Sule Girmen</name>
</author>
<author><name sortKey="Fink, J Stephen" sort="Fink, J Stephen" uniqKey="Fink J" first="J. Stephen" last="Fink">J. Stephen Fink</name>
</author>
<author><name sortKey="Tivol, Elizabeth" sort="Tivol, Elizabeth" uniqKey="Tivol E" first="Elizabeth" last="Tivol">Elizabeth Tivol</name>
</author>
<author><name sortKey="Shalish, Christo" sort="Shalish, Christo" uniqKey="Shalish C" first="Christo" last="Shalish">Christo Shalish</name>
</author>
<author><name sortKey="Trofatter, James" sort="Trofatter, James" uniqKey="Trofatter J" first="James" last="Trofatter">James Trofatter</name>
</author>
<author><name sortKey="Baenziger, John" sort="Baenziger, John" uniqKey="Baenziger J" first="John" last="Baenziger">John Baenziger</name>
</author>
<author><name sortKey="Diamond, Shirley" sort="Diamond, Shirley" uniqKey="Diamond S" first="Shirley" last="Diamond">Shirley Diamond</name>
</author>
<author><name sortKey="Markham, Charles" sort="Markham, Charles" uniqKey="Markham C" first="Charles" last="Markham">Charles Markham</name>
</author>
<author><name sortKey="Sullivan, Jack" sort="Sullivan, Jack" uniqKey="Sullivan J" first="Jack" last="Sullivan">Jack Sullivan</name>
</author>
<author><name sortKey="Growdon, John" sort="Growdon, John" uniqKey="Growdon J" first="John" last="Growdon">John Growdon</name>
</author>
<author><name sortKey="Breakefield, Xandra O" sort="Breakefield, Xandra O" uniqKey="Breakefield X" first="Xandra O." last="Breakefield">Xandra O. Breakefield</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:64432B267293EF1A4DE75E647985C6411C139AD7</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/mds.870090304</idno>
<idno type="url">https://api.istex.fr/document/64432B267293EF1A4DE75E647985C6411C139AD7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D97</idno>
<idno type="wicri:Area/Istex/Curation">000D97</idno>
<idno type="wicri:Area/Istex/Checkpoint">003F04</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Hotamisligil G:hereditary:variations:in</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7913737</idno>
<idno type="wicri:Area/PubMed/Corpus">004B16</idno>
<idno type="wicri:Area/PubMed/Curation">004B16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004B18</idno>
<idno type="wicri:Area/Ncbi/Merge">004810</idno>
<idno type="wicri:Area/Ncbi/Curation">004810</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004810</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Hotamisligil G:hereditary:variations:in</idno>
<idno type="wicri:Area/Main/Merge">008D60</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease</title>
<author><name sortKey="Hotamisligil, Gokhan S" sort="Hotamisligil, Gokhan S" uniqKey="Hotamisligil G" first="Gokhan S." last="Hotamisligil">Gokhan S. Hotamisligil</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Girmen, A Sule" sort="Girmen, A Sule" uniqKey="Girmen A" first="A. Sule" last="Girmen">A. Sule Girmen</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Fink, J Stephen" sort="Fink, J Stephen" uniqKey="Fink J" first="J. Stephen" last="Fink">J. Stephen Fink</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tivol, Elizabeth" sort="Tivol, Elizabeth" uniqKey="Tivol E" first="Elizabeth" last="Tivol">Elizabeth Tivol</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shalish, Christo" sort="Shalish, Christo" uniqKey="Shalish C" first="Christo" last="Shalish">Christo Shalish</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Trofatter, James" sort="Trofatter, James" uniqKey="Trofatter J" first="James" last="Trofatter">James Trofatter</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Baenziger, John" sort="Baenziger, John" uniqKey="Baenziger J" first="John" last="Baenziger">John Baenziger</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Psychiatry and Pathology, Alcohol Research Center, Indiana University Medical Center, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Diamond, Shirley" sort="Diamond, Shirley" uniqKey="Diamond S" first="Shirley" last="Diamond">Shirley Diamond</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California, Los Angeles, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Markham, Charles" sort="Markham, Charles" uniqKey="Markham C" first="Charles" last="Markham">Charles Markham</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California, Los Angeles, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sullivan, Jack" sort="Sullivan, Jack" uniqKey="Sullivan J" first="Jack" last="Sullivan">Jack Sullivan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Psychiatry and Pathology, Alcohol Research Center, Indiana University Medical Center, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Growdon, John" sort="Growdon, John" uniqKey="Growdon J" first="John" last="Growdon">John Growdon</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Breakefield, Xandra O" sort="Breakefield, Xandra O" uniqKey="Breakefield X" first="Xandra O." last="Breakefield">Xandra O. Breakefield</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1994">1994</date>
<biblScope unit="vol">9</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="305">305</biblScope>
<biblScope unit="page" to="310">310</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">64432B267293EF1A4DE75E647985C6411C139AD7</idno>
<idno type="DOI">10.1002/mds.870090304</idno>
<idno type="ArticleID">MDS870090304</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alleles</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Gene Frequency (genetics)</term>
<term>Genetic Variation</term>
<term>Haplotypes (genetics)</term>
<term>Humans</term>
<term>Infant</term>
<term>Isoenzymes (blood)</term>
<term>Isoenzymes (genetics)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Monoamine Oxidase (blood)</term>
<term>Monoamine Oxidase (genetics)</term>
<term>Monoamine oxidase</term>
<term>Parkinson Disease (enzymology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson's disease</term>
<term>Polymorphism, Restriction Fragment Length</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Isoenzymes</term>
<term>Monoamine Oxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Gene Frequency</term>
<term>Haplotypes</term>
<term>Isoenzymes</term>
<term>Monoamine Oxidase</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alleles</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Genetic Variation</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polymorphism, Restriction Fragment Length</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of dopaminergic neurons in the brainstem. Recent studies suggest that several genes may have a role in determining individual susceptibility to this disease, and the degradative enzyme monoamine oxidase (MAO) has been implicated in the disease process. Wide differences in activity levels for both forms of this enzyme (MAO‐A and MAO‐B) exist in the human population, and levels of both are genetically determined. Here we have compared the frequency of haplotypes at the MAOA and MAOB loci on the X chromosome in 91 male patients with PD and 129 male controls. Alleles were marked using two restriction fragment length polymorphisms (RFLPs), a (GT)n repeat in the MAOA locus, and a (GT)n repeat in the MAOB locus. One particular haplotype marked by the RFLP's at MAOA was three times more frequent in patients with PD as compared with controls, and the overall distribution of these alleles was significantly different (p =0.03) between these two groups. Another MAOA haplotype was about threefold more common in controls than in patients with PD (p = 0.005). No associations were observed between individual MAOB alleles and the disease state, but the frequency distribution for all alleles was significantly different in the two populations (p = 0.046). These findings support the idea that the MAO genes may be among the herediatary factors that influence susceptibility of individuals to PD.</div>
</front>
</TEI>
<double doi="10.1002/mds.870090304"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease</title>
<author><name sortKey="Hotamisligil, Gokhan S" sort="Hotamisligil, Gokhan S" uniqKey="Hotamisligil G" first="Gokhan S." last="Hotamisligil">Gokhan S. Hotamisligil</name>
</author>
<author><name sortKey="Girmen, A Sule" sort="Girmen, A Sule" uniqKey="Girmen A" first="A. Sule" last="Girmen">A. Sule Girmen</name>
</author>
<author><name sortKey="Fink, J Stephen" sort="Fink, J Stephen" uniqKey="Fink J" first="J. Stephen" last="Fink">J. Stephen Fink</name>
</author>
<author><name sortKey="Tivol, Elizabeth" sort="Tivol, Elizabeth" uniqKey="Tivol E" first="Elizabeth" last="Tivol">Elizabeth Tivol</name>
</author>
<author><name sortKey="Shalish, Christo" sort="Shalish, Christo" uniqKey="Shalish C" first="Christo" last="Shalish">Christo Shalish</name>
</author>
<author><name sortKey="Trofatter, James" sort="Trofatter, James" uniqKey="Trofatter J" first="James" last="Trofatter">James Trofatter</name>
</author>
<author><name sortKey="Baenziger, John" sort="Baenziger, John" uniqKey="Baenziger J" first="John" last="Baenziger">John Baenziger</name>
</author>
<author><name sortKey="Diamond, Shirley" sort="Diamond, Shirley" uniqKey="Diamond S" first="Shirley" last="Diamond">Shirley Diamond</name>
</author>
<author><name sortKey="Markham, Charles" sort="Markham, Charles" uniqKey="Markham C" first="Charles" last="Markham">Charles Markham</name>
</author>
<author><name sortKey="Sullivan, Jack" sort="Sullivan, Jack" uniqKey="Sullivan J" first="Jack" last="Sullivan">Jack Sullivan</name>
</author>
<author><name sortKey="Growdon, John" sort="Growdon, John" uniqKey="Growdon J" first="John" last="Growdon">John Growdon</name>
</author>
<author><name sortKey="Breakefield, Xandra O" sort="Breakefield, Xandra O" uniqKey="Breakefield X" first="Xandra O." last="Breakefield">Xandra O. Breakefield</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:64432B267293EF1A4DE75E647985C6411C139AD7</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/mds.870090304</idno>
<idno type="url">https://api.istex.fr/document/64432B267293EF1A4DE75E647985C6411C139AD7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D97</idno>
<idno type="wicri:Area/Istex/Curation">000D97</idno>
<idno type="wicri:Area/Istex/Checkpoint">003F04</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Hotamisligil G:hereditary:variations:in</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease</title>
<author><name sortKey="Hotamisligil, Gokhan S" sort="Hotamisligil, Gokhan S" uniqKey="Hotamisligil G" first="Gokhan S." last="Hotamisligil">Gokhan S. Hotamisligil</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Girmen, A Sule" sort="Girmen, A Sule" uniqKey="Girmen A" first="A. Sule" last="Girmen">A. Sule Girmen</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Fink, J Stephen" sort="Fink, J Stephen" uniqKey="Fink J" first="J. Stephen" last="Fink">J. Stephen Fink</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Tivol, Elizabeth" sort="Tivol, Elizabeth" uniqKey="Tivol E" first="Elizabeth" last="Tivol">Elizabeth Tivol</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shalish, Christo" sort="Shalish, Christo" uniqKey="Shalish C" first="Christo" last="Shalish">Christo Shalish</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Trofatter, James" sort="Trofatter, James" uniqKey="Trofatter J" first="James" last="Trofatter">James Trofatter</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Microbiology and Molecular Genetics, and Neuroscience Program, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Baenziger, John" sort="Baenziger, John" uniqKey="Baenziger J" first="John" last="Baenziger">John Baenziger</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Psychiatry and Pathology, Alcohol Research Center, Indiana University Medical Center, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Diamond, Shirley" sort="Diamond, Shirley" uniqKey="Diamond S" first="Shirley" last="Diamond">Shirley Diamond</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California, Los Angeles, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Markham, Charles" sort="Markham, Charles" uniqKey="Markham C" first="Charles" last="Markham">Charles Markham</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, School of Medicine, University of California, Los Angeles, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sullivan, Jack" sort="Sullivan, Jack" uniqKey="Sullivan J" first="Jack" last="Sullivan">Jack Sullivan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Indiana</region>
</placeName>
<wicri:cityArea>Departments of Psychiatry and Pathology, Alcohol Research Center, Indiana University Medical Center, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Growdon, John" sort="Growdon, John" uniqKey="Growdon J" first="John" last="Growdon">John Growdon</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Breakefield, Xandra O" sort="Breakefield, Xandra O" uniqKey="Breakefield X" first="Xandra O." last="Breakefield">Xandra O. Breakefield</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Molecular Neurogenetics Unit, Neurology Service, Massachusetts General Hospital, Charlestown</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1994">1994</date>
<biblScope unit="vol">9</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="305">305</biblScope>
<biblScope unit="page" to="310">310</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">64432B267293EF1A4DE75E647985C6411C139AD7</idno>
<idno type="DOI">10.1002/mds.870090304</idno>
<idno type="ArticleID">MDS870090304</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Monoamine oxidase</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of dopaminergic neurons in the brainstem. Recent studies suggest that several genes may have a role in determining individual susceptibility to this disease, and the degradative enzyme monoamine oxidase (MAO) has been implicated in the disease process. Wide differences in activity levels for both forms of this enzyme (MAO‐A and MAO‐B) exist in the human population, and levels of both are genetically determined. Here we have compared the frequency of haplotypes at the MAOA and MAOB loci on the X chromosome in 91 male patients with PD and 129 male controls. Alleles were marked using two restriction fragment length polymorphisms (RFLPs), a (GT)n repeat in the MAOA locus, and a (GT)n repeat in the MAOB locus. One particular haplotype marked by the RFLP's at MAOA was three times more frequent in patients with PD as compared with controls, and the overall distribution of these alleles was significantly different (p =0.03) between these two groups. Another MAOA haplotype was about threefold more common in controls than in patients with PD (p = 0.005). No associations were observed between individual MAOB alleles and the disease state, but the frequency distribution for all alleles was significantly different in the two populations (p = 0.046). These findings support the idea that the MAO genes may be among the herediatary factors that influence susceptibility of individuals to PD.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.</title>
<author><name sortKey="Hotamisligil, G S" sort="Hotamisligil, G S" uniqKey="Hotamisligil G" first="G S" last="Hotamisligil">G S Hotamisligil</name>
<affiliation><nlm:affiliation>Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown.</nlm:affiliation>
<wicri:noCountry code="subField">Charlestown</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Girmen, A S" sort="Girmen, A S" uniqKey="Girmen A" first="A S" last="Girmen">A S Girmen</name>
</author>
<author><name sortKey="Fink, J S" sort="Fink, J S" uniqKey="Fink J" first="J S" last="Fink">J S Fink</name>
</author>
<author><name sortKey="Tivol, E" sort="Tivol, E" uniqKey="Tivol E" first="E" last="Tivol">E. Tivol</name>
</author>
<author><name sortKey="Shalish, C" sort="Shalish, C" uniqKey="Shalish C" first="C" last="Shalish">C. Shalish</name>
</author>
<author><name sortKey="Trofatter, J" sort="Trofatter, J" uniqKey="Trofatter J" first="J" last="Trofatter">J. Trofatter</name>
</author>
<author><name sortKey="Baenziger, J" sort="Baenziger, J" uniqKey="Baenziger J" first="J" last="Baenziger">J. Baenziger</name>
</author>
<author><name sortKey="Diamond, S" sort="Diamond, S" uniqKey="Diamond S" first="S" last="Diamond">S. Diamond</name>
</author>
<author><name sortKey="Markham, C" sort="Markham, C" uniqKey="Markham C" first="C" last="Markham">C. Markham</name>
</author>
<author><name sortKey="Sullivan, J" sort="Sullivan, J" uniqKey="Sullivan J" first="J" last="Sullivan">J. Sullivan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7913737</idno>
<idno type="pmid">7913737</idno>
<idno type="doi">10.1002/mds.870090304</idno>
<idno type="wicri:Area/PubMed/Corpus">004B16</idno>
<idno type="wicri:Area/PubMed/Curation">004B16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004B18</idno>
<idno type="wicri:Area/Ncbi/Merge">004810</idno>
<idno type="wicri:Area/Ncbi/Curation">004810</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004810</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Hotamisligil G:hereditary:variations:in</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease.</title>
<author><name sortKey="Hotamisligil, G S" sort="Hotamisligil, G S" uniqKey="Hotamisligil G" first="G S" last="Hotamisligil">G S Hotamisligil</name>
<affiliation><nlm:affiliation>Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown.</nlm:affiliation>
<wicri:noCountry code="subField">Charlestown</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Girmen, A S" sort="Girmen, A S" uniqKey="Girmen A" first="A S" last="Girmen">A S Girmen</name>
</author>
<author><name sortKey="Fink, J S" sort="Fink, J S" uniqKey="Fink J" first="J S" last="Fink">J S Fink</name>
</author>
<author><name sortKey="Tivol, E" sort="Tivol, E" uniqKey="Tivol E" first="E" last="Tivol">E. Tivol</name>
</author>
<author><name sortKey="Shalish, C" sort="Shalish, C" uniqKey="Shalish C" first="C" last="Shalish">C. Shalish</name>
</author>
<author><name sortKey="Trofatter, J" sort="Trofatter, J" uniqKey="Trofatter J" first="J" last="Trofatter">J. Trofatter</name>
</author>
<author><name sortKey="Baenziger, J" sort="Baenziger, J" uniqKey="Baenziger J" first="J" last="Baenziger">J. Baenziger</name>
</author>
<author><name sortKey="Diamond, S" sort="Diamond, S" uniqKey="Diamond S" first="S" last="Diamond">S. Diamond</name>
</author>
<author><name sortKey="Markham, C" sort="Markham, C" uniqKey="Markham C" first="C" last="Markham">C. Markham</name>
</author>
<author><name sortKey="Sullivan, J" sort="Sullivan, J" uniqKey="Sullivan J" first="J" last="Sullivan">J. Sullivan</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alleles</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Gene Frequency (genetics)</term>
<term>Genetic Variation</term>
<term>Haplotypes (genetics)</term>
<term>Humans</term>
<term>Infant</term>
<term>Isoenzymes (blood)</term>
<term>Isoenzymes (genetics)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Monoamine Oxidase (blood)</term>
<term>Monoamine Oxidase (genetics)</term>
<term>Parkinson Disease (enzymology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Polymorphism, Restriction Fragment Length</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Isoenzymes</term>
<term>Monoamine Oxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Gene Frequency</term>
<term>Haplotypes</term>
<term>Isoenzymes</term>
<term>Monoamine Oxidase</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alleles</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Genetic Variation</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polymorphism, Restriction Fragment Length</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a common neurodegenerative disorder caused by loss of dopaminergic neurons in the brainstem. Recent studies suggest that several genes may have a role in determining individual susceptibility to this disease, and the degradative enzyme monoamine oxidase (MAO) has been implicated in the disease process. Wide differences in activity levels for both forms of this enzyme (MAO-A and MAO-B) exist in the human population, and levels of both are genetically determined. Here we have compared the frequency of haplotypes at the MAOA and MAOB loci on the X chromosome in 91 male patients with PD and 129 male controls. Alleles were marked using two restriction fragment length polymorphisms (RFLPs), a (GT)n repeat in the MAOA locus, and a (GT)n repeat in the MAOB locus. One particular haplotype marked by the RFLP's at MAOA was three times more frequent in patients with PD as compared with controls, and the overall distribution of these alleles was significantly different (p = 0.03) between these two groups. Another MAOA haplotype was about threefold more common in controls than in patients with PD (p = 0.005). No associations were observed between individual MAOB alleles and the disease state, but the frequency distribution for all alleles was significantly different in the two populations (p = 0.046). These findings support the idea that the MAO genes may be among the hereditary factors that influence susceptibility of individuals to PD.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008D60 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 008D60 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:64432B267293EF1A4DE75E647985C6411C139AD7 |texte= Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |